University of Maryland Greenebaum Cancer Center


“Best Hospitals” cancer-care rank: 39

“Best Hospitals” cancer-care score: 55.5/100

Founded: 1981

Beds: 819

Clinicians/researchers: 233


  • (800) 888-8823
  • 22 South Greene St., Baltimore, MD 21201




Research focus: 

Experimental therapeutics, molecular and structural biology, tumor immunology and immunotherapy, viral oncology, and cancer pain studies.


Clinic at-a-glance:

Greenebaum Cancer Center garners top grades from U.S. News & World Report for patient survival, use of advanced technology, nurse-to-patient ratio, and availability of key services. A National Cancer Institute-designated comprehensive cancer center and an American Nurses Credentialing Center-certified nursing magnet, its patients are seen promptly by internationally recognized experts in cancer care. The institution offers what it refers to as “Operating Rooms of the Future” where technologies such as robot-assisted surgery, stereotactic body radiotherapy, intensity modulated radiation therapy, Gamma Knife radiosurgery, proton therapy, cryosurgery, and targeted chemotherapy drugs are utilized. Greenebaum employs a “bench to bedside” approach to research in order to expedite the transfer of knowledge from laboratory to clinic. It offers access to more than 200 clinical trials.